PMID- 31146011 OWN - NLM STAT- MEDLINE DCOM- 20200504 LR - 20200505 IS - 1089-8611 (Electronic) IS - 1089-8603 (Linking) VI - 90 DP - 2019 Sep 1 TI - Hydrogen sulfide suppresses homocysteine-induced glial activation and inflammatory response. PG - 15-28 LID - S1089-8603(18)30369-0 [pii] LID - 10.1016/j.niox.2019.05.008 [doi] AB - Neuro-inflammation plays a critical role in hyperhomocysteinemia (HHcy)-associated neurodegenerative disorders. Hydrogen sulfide (H(2)S) has been suggested as an endogenous neuromodulator and potent anti-inflammatory molecule. In present study, we have investigated the effect of NaHS supplementation (a H(2)S source) on inflammatory response in animals subjected to HHcy. NaHS adminstration restored the decreased levels of H(2)S and polysulfides with a concomitant increase in the activity of cystathionase (CSE) and cystathionine beta-synthase (CBS) in the brain regions of HHcy animals. NaHS supplementation reduced the expression of glial fibrillary acidic protein (GFAP) and ionized calcium binding adaptor molecule 1 (Iba1) suggesting attenuation of astrocyte and microglia activation in HHcy animals. Tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1) were decreased in the cortex and hippocampus of HHcy animals following NaHS supplementation. Moreover, NaHS supplementation also decreased the TNF-alpha, IL-6 and MCP-1 in the serum of HHcy animals. NaHS supplementation reduced nitrite levels, 3-nitrotyrosine (3-NT) modified proteins and inducible nitric oxide synthase (iNOS) in the cortex and hippocampus of HHcy animals. However, NaHS administration increased endothelial nitric oxide synthase (eNOS) expression in brain regions of Hcy treated animals. Expression of platelet endothelial cell adhesion molecule (PECAM) was decreased in the microvessels from HHcy animals supplemented with NaHS. Furthermore, HHcy-induced memory deficits assessed by Morris water maze and novel object recognition test were reversed by NaHS administration. Taken together, the findings suggest that NaHS supplementation ameliorates Hcy-induced glia mediated inflammatory response and cognitive deficits. Therefore, H(2)S may be a novel therapeutic molecule to treat HHcy associated neurological disorders and neuro-inflammatory conditions. CI - Copyright (c) 2019 Elsevier Inc. All rights reserved. FAU - Kumar, Mohit AU - Kumar M AD - Department of Biochemistry, Basic Medical Science Block-II, Panjab University, Chandigarh, 160014, India. FAU - Sandhir, Rajat AU - Sandhir R AD - Department of Biochemistry, Basic Medical Science Block-II, Panjab University, Chandigarh, 160014, India. Electronic address: sandhir@pu.ac.in. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20190528 PL - United States TA - Nitric Oxide JT - Nitric oxide : biology and chemistry JID - 9709307 RN - 0LVT1QZ0BA (Homocysteine) RN - YY9FVM7NSN (Hydrogen Sulfide) SB - IM MH - Animals MH - Homocysteine/*antagonists & inhibitors/pharmacology MH - Hydrogen Sulfide/*pharmacology MH - Inflammation/*drug therapy/metabolism MH - Male MH - Neuroglia/*drug effects/metabolism MH - Rats MH - Rats, Sprague-Dawley OTO - NOTNLM OT - Astrocytes OT - Glia OT - Homocysteine OT - Hydrogen sulfide OT - Inflammation OT - Memory EDAT- 2019/05/31 06:00 MHDA- 2020/05/06 06:00 CRDT- 2019/05/31 06:00 PHST- 2018/12/17 00:00 [received] PHST- 2019/04/30 00:00 [revised] PHST- 2019/05/26 00:00 [accepted] PHST- 2019/05/31 06:00 [pubmed] PHST- 2020/05/06 06:00 [medline] PHST- 2019/05/31 06:00 [entrez] AID - S1089-8603(18)30369-0 [pii] AID - 10.1016/j.niox.2019.05.008 [doi] PST - ppublish SO - Nitric Oxide. 2019 Sep 1;90:15-28. doi: 10.1016/j.niox.2019.05.008. Epub 2019 May 28.